Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

COVID-19

Free Subscription 21.09.2026 1 Am J Obstet Gynecol 3 Antiviral Res 2 BMJ 5 Emerg Infect Dis 1 Eur J Radiol 2 Int J Infect Dis 3 J Infect 2 J Med Virol 1 J Virol 1 Nature

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. HABBOUS S, Surani A, Leyland NA, Murji A, et al
   Uptake and outcomes associated with outpatient hysterectomy in Ontario, Canada.
   Am J Obstet Gynecol. 2026 Sep 18:S0002-9378(26)00500.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. DU PONT V, Han D, Li J, Rodriguez L, et al
   Remdesivir maintains antiviral potency against clinically relevant SARS-CoV-2 Nsp12 substitutions.
   Antiviral Res. 2026;255:106533.
   PubMed         Abstract available
   
   
3. MARTINEZ-ARRIBAS B, Diaz-Gonzalez R, Weaver J, Walden M, et al
   Identification of 1,2-dihydroquinazolin-2-ones kinase inhibitors as anti-coronavirus agents.
   Antiviral Res. 2026 Sep 15:106534. doi: 10.1016/j.antiviral.2026.106534.
   PubMed         Abstract available
   
   
4. NAGAHAWATTA DP, Jeong SH, Liyanage NM, Jayawardena TU, et al
   Marine phlorotannins block SARS-CoV-2 entry via ACE2 and attenuate pulmonary inflammation in K18-hACE2 transgenic mice.
   Antiviral Res. 2026 Sep 15:106532. doi: 10.1016/j.antiviral.2026.106532.
   PubMed         Abstract available
   
   

   
   BMJ

5. WISE J
   Covid-19 inquiry: Additional psychological support for doctors would be rolled out in future pandemic, government says.
   BMJ. 2026;394:e100866.
   PubMed        
   
   
6. WILLMAN D
   US officials knew covid vaccine safety system was flawed-but turned aside the FDA doctor who alerted them.
   BMJ. 2026;394:e100806.
   PubMed        
   
   

   
   Emerg Infect Dis

7. DUTCHER HA, Antkiewicz DS, Roguet AJ, Shafer MM, et al
   Implementation and Early Outcomes of Laboratory Proficiency Testing Program for the National Wastewater Surveillance System, United States, 2024.
   Emerg Infect Dis. 2026;32:19-25.
   PubMed         Abstract available
   
   
8. BI K, Sandoval M, Nguyen T, Perez I, et al
   Temporal Alignment of Wastewater Signals with Clinical Indicators of Respiratory Illness Postpandemic, Texas, USA.
   Emerg Infect Dis. 2026;32:43-52.
   PubMed         Abstract available
   
   
9. MARK-CAREW M, Bias M, Reckling S, Madhobi K, et al
   Progress and Expansion of the National Wastewater Surveillance System, United States, 2020-2024.
   Emerg Infect Dis. 2026;32:3-13.
   PubMed         Abstract available
   
   
10. LEFFERTS B, Leary A, Bruden D, Blake I, et al
    Wastewater Respiratory Virus Surveillance in Remote Community, Alaska, USA, 2022-2024.
    Emerg Infect Dis. 2026;32:71-79.
    PubMed         Abstract available
    
    
11. MOORE JT, Rose-McCully K, Valencia D, Turner H, et al
    Exploration of Public Perceptions of Wastewater Surveillance, United States, June 2024.
    Emerg Infect Dis. 2026;32:115-118.
    PubMed         Abstract available
    
    

    
    Eur J Radiol

12. SCHMIDT K, Steinberger M, Woellert S, Klein M, et al
    CT radiation exposure of emergency department patients before, during and after the COVID-19 pandemic.
    Eur J Radiol. 2026;205:113211.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

13. HERRERO RL, Jimenez PM, Del Olmo DO, Prieto-Utrera RD, et al
    Epidemiological trends in sepsis in Spain: incidence, in-hospital mortality, and healthcare burden (2017-2022).
    Int J Infect Dis. 2026 Sep 16:109121. doi: 10.1016/j.ijid.2026.109121.
    PubMed         Abstract available
    
    
14. XU M, Huang Y, Ma H, Wu Z, et al
    A Multi-model Counterfactual Analysis of Human Brucellosis in China: Spatiotemporal Epidemiology and Heterogeneous Pandemic-associated Deviations in 2020.
    Int J Infect Dis. 2026 Sep 15:109119. doi: 10.1016/j.ijid.2026.109119.
    PubMed         Abstract available
    
    

    
    J Infect

15. ORTEGA-FRANCISCO S, Prudente de Aquino MT, Chiuppesi F, Gutierrez-Franco MA Jr, et al
    Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.
    J Infect. 2026;93:106855.
    PubMed         Abstract available
    
    
16. HARRIS R, Thirard R, Iftikhar H, Middleditch A, et al
    Corrigendum to "Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial" [J Infect 93 (2026) 106784].
    J Infect. 2026;93:106853.
    PubMed        
    
    
17. BERES SB, Pagnossin D, Olsen RJ, Long SW, et al
    Clinical and population genomic epidemiology of invasive group A streptococcus in Scotland, 2014-2024.
    J Infect. 2026 Sep 18:106860. doi: 10.1016/j.jinf.2026.106860.
    PubMed         Abstract available
    
    

    
    J Med Virol

18. YANG T, Zhang R, Qin S, Zheng Y, et al
    Cross-Neutralization Responses and Persistent Symptoms After SARS-CoV-2 Breakthrough Infections.
    J Med Virol. 2026;98:e71153.
    PubMed         Abstract available
    
    
19. TURANLI EE, Yildirim Arslan S, Dinc F
    Clinical Outcomes in Pediatric COVID-19 Across Two Time Periods: The Role of Coinfection, Age, and Inflammatory Markers.
    J Med Virol. 2026;98:e71156.
    PubMed         Abstract available
    
    

    
    J Virol

20. BUGA CC, Valerio M, Alenquer M, Pires de Miranda M, et al
    Insights into the mechanism of action of the bipartite fusion module of SARS-CoV-2 spike protein.
    J Virol. 2026 Sep 15:e0068826. doi: 10.1128/jvi.00688.
    PubMed         Abstract available
    
    

    
    Nature

21. VARILLY P, Schifferli M, Yang K, Cronan P, et al
    Scalable near-real-time Bayesian phylogenetics for outbreaks with Delphy.
    Nature. 2026 Sep 16. doi: 10.1038/s41586-026-11012.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum